Galanin
Mostrando 1-12 de 69 artigos, teses e dissertações.
-
1. Diagnostic value of serum levels of galanin and obestatin in patients with gastric cancer
SUMMARY OBJECTIVE: Gastric cancer ranks the third among the cancer-related deaths. It is diagnosed at advanced stage in many patients due to malignant proliferation and has a poor prognosis. Currently, no instrument or biomarker has been proven to diagnose the disease before the advanced stages. This study aimed to measure the serum levels of galanin and ob
Revista da Associação Médica Brasileira. Publicado em: 2022
-
2. Adenomas hipofisarios : estudo clinico, morfologico e morfometrico; busca de fatores de prognostico utilizando o metodo imunoistoquimico / Pituitary adenomas : a clinical, morphological and morphometric study : searching for prognostic factors with the immunohistochemical method
Pituitary Adenomas (PA) are an easily identifiable and benign epithelial neoplasia. They are clinically detected through symptoms of an increased or decreased hormone rate and/or alterations of intra-cranial mass. They are classed in accordance with radiological / macroscopical aspects (macro versus microadenoma / invasive versus non-invasive), functional st
Publicado em: 2007
-
3. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.
The galanin-receptor ligand M40 [galanin-(1-12)-Pro3-(Ala-Leu)2-Ala amide] binds with high affinity to [mono[125I]iodo-Tyr26]galanin-binding sites in hippocampal, hypothalamic, and spinal cord membranes and in membranes from Rin m5F rat insulinoma cells (IC50 = 3-15 nM). Receptor autoradiographic studies show that M40 (1 microM) displaces [mono[125I]iodo-Tyr
-
4. N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor.
The galanin N-terminal fragment [galanin-(1-16)] has been prepared by solid-phase synthesis and by enzymic cleavage of galanin by endoproteinase Asp-N. This peptide fragment displaced 125I-labeled galanin in receptor autoradiography experiments on rat forebrain and spinal cord and in equilibrium binding experiments from high-affinity binding sites in the ven
-
5. Possible evidence for endogenous production of a novel galanin-like peptide.
Galanin mRNA and peptide are not detectable in normal islets. We studied the effect of galanin antagonists on insulin secretion in the rat beta cell line, RIN5AH, and in perifused rat islets. In RIN cell membranes galanin and its antagonists showed high affinity for 125I-galanin binding sites [Kd: (galanin) 0.03+/-0.01; Ki for galanin antagonists: (C7) 0.12+
-
6. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
Structure-activity studies demonstrate that galanin fragments 1-15 and 2-29 are fully active, whereas fragment 3-29 has been reported to be inactive, in a number of different in vivo models. M15, a chimeric peptide comprising galanin 1-13 and substance P5-11, has recently been found to be a potent galanin antagonist. Direct effects of galanin at the level of
-
7. Purification of a galanin receptor from pig brain.
A galanin receptor protein was solubilized with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) from pig brain membranes and then purified by single-step affinity chromatography. The product exhibits saturable and specific binding for galanin with a binding activity of 17 nmol/mg of protein and a dissociation constant (Kd) of 10 nM. This re
-
8. The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal
Much research has focused on pathways leading to opiate addiction. Pathways opposing addiction are more difficult to study but may be critical in developing interventions to combat drug dependence and withdrawal. Galanin decreases firing of locus coeruleus neurons, an effect hypothesized to decrease signs of opiate withdrawal. The current study addresses
National Academy of Sciences.
-
9. Anticonvulsant activity of a nonpeptide galanin receptor agonist
Galanin is a neuropeptide with a wide variety of biological functions, including that of a strong endogenous anticonvulsant. No nonpeptide ligands, capable of activating galanin receptors, are available today. Based on known pharmacophores of galanin, a combinatorial library was designed, synthesized, and screened at the rat hippocampal galanin receptor. A l
The National Academy of Sciences.
-
10. Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin
The neuropeptide galanin has been shown to suppress epileptic seizures. In cortical and hippocampal areas, galanin is normally mainly expressed in noradrenergic afferents. We have generated a mouse overexpressing galanin in neurons under the platelet-derived growth factor B promoter. RIA and HPLC analysis revealed up to 8-fold higher levels of galanin in tra
The National Academy of Sciences.
-
11. Distribution of galanin immunoreactivity in the respiratory tract of pig, guinea pig, rat, and dog.
Galanin, a newly discovered peptide isolated from porcine intestine, is known to cause contraction in rat smooth muscle preparations and to induce hyperglycaemia in dogs. By the use of radioimmunoassay and immunohistochemical techniques the concentration and distribution of galanin immunoreactivity were determined in several areas of the respiratory tract of
-
12. Galanin acts as a neuroprotective factor to the hippocampus
The expression of the neuropeptide galanin is markedly up-regulated in many areas of the central and peripheral nervous system after injury. We have recently demonstrated that peripheral sensory neurons depend on galanin for neurite extension after injury, mediated by activation of the second galanin receptor subtype (GALR2). We therefore hypothesized that g
National Academy of Sciences.